April 24, 2016
What could a TMA Membership mean for you, your practice, and your patients
Pharmaceuticals
The Texas State Board of Pharmacy is limiting prescriptions of chloroquine, hydroxychloroquine, mefloquine, and azithromycin amid reports that hospitals and prescribers are stocking up on some of those drugs even though they are not proven to treat COVID-19 effectively. Read More
Thanks to Texas Medical Association advocacy, the Texas Medical Boardhas refocused its guidance on when physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing certain medications starting March 1. Read More
I won’t be surprised if physicians around the state are feeling a little angst and anger over the coming March 1 requirement for physicians to check the Texas prescription monitoring program (PMP) before writing prescriptions for opioids, benzodiazepines, barbiturates, and carisoprodol. I don’t fault them one bit. This is just one more administrative burden placed on physicians. But I want all of you to understand just how much worse it would have been without the intervention of the Texas Medical Association. Read More
More Related Stories
Read the Latest Issue